Global Stories
Taking Action for Health is Wealth
13 Oct 2022, noon in #insulin4all USA, Global Stories, News & Statements by T1International
T1International’s virtual #insulin4all Summit, Health is Wealth, was held on September 24th. Thank you everyone for your participation and read our recap here! Read more
5 Ways To Combat Pharma Talking Points with Just the Facts
12 Aug 2022, 6 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Misinformation about diabetes and insulin is all too regularly spread in both the media and on social platforms. In this post, we outline 5 of the most common talking points used to explain away price gouging and how we can use the facts to overcome this narrative. Read more
Calling for Empowered Implementation of Global Diabetes Coverage Targets
11 Jul 2022, 9:59 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
At the 75th World Health Assembly (WHA) of the World Health Organization (WHO), member states adopted the first ever ‘Global Diabetes Coverage Targets,’ meant to steer the course of diabetes diagnosis and treatment for the next 8 years. Read more
Global Advocacy Success Series: Lejla Druškić, Bosnia and Herzegovina
2 May 2022, 6:48 p.m. in Global Stories, Interviews, News & Statements by Katie Souris
Lejla Druškić, Global Advocate from Bosnia and Herzegovina, is a fearless speaker. Since joining T1International’s Global Advocacy Network in July 2021, she has been an invited speaker at the 3rd annual Congress of Diabetologists and Endocrinologists of Bosnia and Herzegovina, serving as a patient representative on a panel of patients and healthcare providers. Read more
The Next 100 Years of Insulin
24 Mar 2022, 11:11 p.m. in #insulin4all USA, Global Stories, News & Statements by Ian Devaney
For some, the first 100 years of insulin has been a great, life-affirming success. For others, it has been a failure, where leaders and organizations in power have chosen profits over the lives and welfare of human beings. So how will we shape the next 100 years? Read more
Global Advocacy Success Series: Zimbabwe #insulin4all
31 Jan 2022, noon in Global Stories, Interviews by Katie Souris
Established in 2021, the T1International Zimbabwe #insulin4all Chapter, led by Global Chapter Representative Laura Munyoro, has made significant strides in developing the structure of their advocacy network and taking action as community leaders. Read more
Global Advocacy Success Series: JohnPeter, Tanzania
3 Nov 2021, 10:02 a.m. in Global Stories, Interviews by Katie Souris
JohnPeter exemplifies the resilient spirit and patient perseverance that any lifelong advocate must have. He says, ''Being a Global Advocate with T1International has taught me the resilience to fight for what I believe in.'' Read more
Global Advocacy Success Series: Cyrine, Lebanon
31 Aug 2021, 4:19 p.m. in Global Stories, Interviews by Katie Souris
T1International has provided tools and support to ensure Cyrine’s plans are detailed and realistic, and allowed her to connect with other advocates around the world who can offer support and guidance. Read more
Redirecting Guilt into Action
16 Jul 2021, 10:04 a.m. in #insulin4all USA, Global Stories by Elizabeth Roosevelt
It’s crucial that those of us who have access to insulin use our platform and privilege to fight for our community and for the people with diabetes who are solely focused on surviving. We must serve as the voice for the people with diabetes who can’t use their own because they’re bogged down working three jobs and choosing between putting food on the table for their family or insulin. Read more
Underrepresented Communities and Navigating the System
14 Jun 2021, 12:52 p.m. in #insulin4all USA, Global Stories by Alzahrra Almajid
Seven years after my diagnosis my brother was also diagnosed with type 1 diabetes which made the already bad financial burden worse. Although all people with diabetes struggle with how expensive diabetes can be, immigrants and people of color often do not have access to quality health insurance (or any access) so they are less likely to benefit from advanced diabetes technology. As I got older I began to understand how difficult it is to navigate a system that makes it harder for people in underrepresented communities to get adequate care. Read more